Skip to main content

Advertisement

Log in

Role of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast Cancer

  • REVIEW ARTICLE
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Breast cancer is the commonest cancer among women and leading cause of cancer related mortality worldwide. Locally advanced breast cancer is the common subgroup of breast cancer encountered in developing countries. The last decade witnessed the voluminous upsurge in the use of positron emission tomography-computed tomography. Its role has been evaluated in different aspects of breast cancer - diagnosing and staging the disease, assessing the therapeutic response to chemotherapy, and restaging the recurrent disease. The present review aims to delineate the current role of positron emission tomography-computed tomography in the management of locally advanced breast cancer, based on available literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–86

    Article  CAS  PubMed  Google Scholar 

  2. Cancer Staging [Internet]. National Cancer Institute. [cited 2015 Apr 12]. Available from: http://www.cancer.gov/cancertopics/diagnosis-staging/staging/staging-fact-sheet

  3. Smith JA, Andreopoulou E (2004) An overview of the status of imaging screening technology for breast cancer. Ann Oncol 15:i18–26

    Article  PubMed  Google Scholar 

  4. Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G (2013) Role of 18 F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer. Nucl Med Commun 34:557–61

    Article  CAS  PubMed  Google Scholar 

  5. Garg PK (2014) Preoperative fluorodeoxyglucose positron emission tomography-computed tomography in papillary thyroid cancer: a futile exercise. J Int Med Res 42:243–4

    Article  PubMed  Google Scholar 

  6. Challa VR, Srivastava A, Dhar A, Parshad R, Bal C, Mohan Reddy Gona R et al (2013) Role of fluorine-18-labeled 2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in the evaluation of axillary lymph node involvement in operable breast cancer in comparison with sentinel lymph node biopsy. Indian J Nucl Med 28:138–43

    Article  PubMed  PubMed Central  Google Scholar 

  7. Deo SVS, Varma MC, Shukla NK (2008) Management of patients with breast cancer: are we ready in India for sentinel lymph node biopsy? Natl Med J India 21:27–30

    CAS  PubMed  Google Scholar 

  8. Groheux D, Hindié E, Rubello D, Espié M, Baillet G, Giacchetti S et al (2009) Should FDG PET/CT be used for the initial staging of breast cancer? Eur J Nucl Med Mol Imaging 36:1539–42

    Article  PubMed  Google Scholar 

  9. Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EAM et al (2008) Breast cancer staging in a single session: whole-body PET/CT mammography. J Nucl Med 49:1215–22

    Article  PubMed  Google Scholar 

  10. Choi YJ, Shin YD, Kang YH, Lee MS, Lee MK, Cho BS et al (2012) The effects of preoperative (18)F-FDG PET/CT in breast cancer patients in comparison to the conventional imaging study. J Breast Cancer 15:441–8

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jung NY, Kim SH, Kim SH, Seo YY, Oh JK, Choi HS et al (2015) Effectiveness of breast MRI and 18 F-FDG PET/CT for the preoperative staging of invasive lobular carcinoma versus ductal carcinoma. J Breast Cancer 18:63–72

    Article  PubMed  PubMed Central  Google Scholar 

  12. Baruah BP, Goyal A, Young P, Douglas-Jones AG, Mansel RE (2010) Axillary node staging by ultrasonography and fine-needle aspiration cytology in patients with breast cancer. Br J Surg 97:680–3

    Article  CAS  PubMed  Google Scholar 

  13. Sianesi M, Ceci G, Ghirarduzzi A, Del Rio P, Guazzi A, Pisanelli B et al (2009) Use of axillary ultrasonography in breast cancer: a useful tool to reduce sentinel node procedures. Ann Ital Chir 80:315–8

    PubMed  Google Scholar 

  14. Van Rijk MC, Deurloo EE, Nieweg OE, Gilhuijs KGA, Peterse JL, Rutgers EJT et al (2006) Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 13:31–5

    Article  PubMed  Google Scholar 

  15. Leenders MWH, Broeders M, Croese C, Richir MC, Go HLS, Langenhorst BLM et al (2012) Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do? Breast Edinb Scotl 21:578–83

    Article  CAS  Google Scholar 

  16. Pritchard KI, Julian JA, Holloway CMB, McCready D, Gulenchyn KY, George R et al (2012) Prospective study of 2-[18 F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. J Clin Oncol 30:1274–9

    Article  CAS  PubMed  Google Scholar 

  17. Cooper KL, Harnan S, Meng Y, Ward SE, Fitzgerald P, Papaioannou D et al (2011) Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol 37:187–98

    Article  CAS  PubMed  Google Scholar 

  18. Robertson IJ, Hand F, Kell MR (2011) FDG-PET/CT in the staging of local/regional metastases in breast cancer. Breast Edinb Scotl 20:491–4

    Article  Google Scholar 

  19. Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C et al (2013) 18 F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging. J Nucl Med 54:5–11

    Article  PubMed  Google Scholar 

  20. Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G et al (2008) Preoperative staging of large primary breast cancer with [18 F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures. J Clin Oncol 26:4746–51

    Article  PubMed  Google Scholar 

  21. Mahner S, Schirrmacher S, Brenner W, Jenicke L, Habermann CR, Avril N et al (2008) Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann Oncol 19:1249–54

    Article  CAS  PubMed  Google Scholar 

  22. Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu T-K, Liu J et al (2011) FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer. Oncologist 16:1111–9

    Article  PubMed  PubMed Central  Google Scholar 

  23. NCCN clinical practice guidelines in oncology (NCCN guidelines®) Breast Cancer, Version 2.2015 [Internet]. [cited 2015 May 10]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

  24. Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. RadioGraphics 27:S215–29

    Article  PubMed  Google Scholar 

  25. Morris PG, Lynch C, Feeney JN, Patil S, Howard J, Larson SM et al (2010) Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer. J Clin Oncol 28:3154–9

    Article  PubMed  PubMed Central  Google Scholar 

  26. Van der Hoeven JJM, Krak NC, Hoekstra OS, Comans EFI, Boom RPA, van Geldere D et al (2004) 18 F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol 22:1253–9

    Article  PubMed  Google Scholar 

  27. Deo SVS, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J (2003) Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol 84:192–7

    Article  CAS  PubMed  Google Scholar 

  28. Ozkan E (2013) Positron emission tomography/computed tomography in locally advanced breast cancer. Exp Oncol 35:253–7

    CAS  PubMed  Google Scholar 

  29. Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L et al (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18 F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 24:5366–72

    Article  PubMed  Google Scholar 

  30. Kumar A, Kumar R, Seenu V, Gupta SD, Chawla M, Malhotra A et al (2009) The role of 18 F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol 19:1347–57

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The author’s declares that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suryanarayana V. S. Deo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garg, P.K., Deo, S.V.S. & Kumar, R. Role of Positron Emission Tomography-Computed Tomography in Locally Advanced Breast Cancer. Indian J Surg Oncol 6, 420–426 (2015). https://doi.org/10.1007/s13193-015-0437-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-015-0437-5

Keywords

Navigation